Thesan Pharmaceuticals Receives $16,000,000 Series A Round
-
Feed Type
-
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=093edf4a-1e83-4c4d-a84a-ae4f81431c2d&Preview=1 -
Date
11/1/2012 -
Company Name
Thesan Pharmaceuticals -
Mailing Address
392 Camino de Estrella San Clemente, CA 92672 -
Company Description
Thesan Pharmaceuticals, Inc. is a preclinical biopharmaceutical company dedicated to the development of novel therapeutics for disorders of the skin. Until recently, there has been comparatively limited innovation in the field of dermatology, where many companies have focused on the reformulation of existing drugs often resulting in marginal patient benefit. In contrast, Thesan is focused on the discovery and development of New Chemical Entities that have the potential to provide significantly improved treatment options to patients. -
Website
http://www.thesanpharma.com -
Transaction Type
Venture Equity -
Transaction Amount
$16,000,000 -
Transaction Round
Series A -
Proceeds Purposes
The company will focus on the development of novel approaches for the treatment of dermatological disorders. -
M&A Terms
-
Venture Investor
Novo A/S -
Venture Investor
Novartis Venture Fund
